Venture capital firm based in London, UK
London-based biotech company AstronauTx secures £48m ($61m) in funding, led by Novartis Venture Fund, to advance their small-molecule drug portfolio and conduct a clinical study in Alzheimer's patients, positioning them for significant progress in Alzheimer's research and potential life-changing treatments. Read more
Biotech | 100.0% |